Cervical Cancer Detection Using Optical Spectroscopy

Part of paid clinical trials in Durham, North Carolina.

Sponsor
Duke University
Study ID
NCT00900575
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Optical Spectroscopy Bench-Top System — DEVICE
    This device is a bench-top optical spectrometer
  • Portable Optical Spectrometer — DEVICE
    This device is a portable optical spectrometer
  • Transvaginal colposcope — DEVICE

Study Details

The objective of the work described in this protocol is to determine the optical signatures of cervical dysplasia using optical technologies.

Key Dates

Start date
May 31, 2006
Status verified
Mar 2026
Primary completion
Jan 31, 2028
Completion
Jan 31, 2028

Study Design

Enrollment
350 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: Colposcope
    Patients referred for GYN procedures. Specifically, patients will be referred for Pap smear, colposcope or LEEP. The intervention for this arm is the use of the bench-top, miniature optical spectrometer or trans-vaginal colposcope

Primary Outcome Measure

Identification of optical signatures of cervical tissue [ Time Frame: Day of procedure (less than 10 minutes) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Duke University Medical CenterDurhamNorth Carolina27710
Nimmi Ramanujam, Ph.D. (PRINCIPAL_INVESTIGATOR)
John Schmitt, M.D. (SUB_INVESTIGATOR)

Find similar trials in Durham, NC

By condition
Cervical cancer
By specialty
OncologyGynecologic oncologyWomen's health
By research site
Duke University Medical Center· Durham, NC

Related Studies